References
1. Javad H, Al-Yarubi S, Chacko AP, Sankhla D, Al-Futasi A, Abdelmogheth
AA, et al. Semilobar Holoprosencephaly with Neurogenic Hypernatraemia:
Two new cases. Sultan Qaboos University medical journal.
2013;13(3):E463-6.
2. Golden JA. Towards a greater understanding of the pathogenesis of
holoprosencephaly. Brain & development. 1999;21(8):513-21.
3. Hasegawa Y, Hasegawa T, Yokoyama T, Kotoh S, Tsuchiya Y.
Holoprosencephaly associated with diabetes insipidus and syndrome of
inappropriate secretion of antidiuretic hormone. The Journal of
pediatrics. 1990;117(5):756-8.
4. Savasta S, Chiapedi S, Borali E, Perrini S, Sepe V, Caimmi S, et al.
Holoprosencephaly with neurogenic hypernatremia: a new case. Child’s
nervous system : ChNS : official journal of the International Society
for Pediatric Neurosurgery. 2008;24(1):139-42.
5. Kourti M, Pavlou E, Rousso I, Economou I, Athanassiadou F.
Holoprosencephaly and diabetes insipidus in a 3-month-old infant.
Journal of child neurology. 2008;23(1):118-20.
6. Di Iorgi N, Napoli F, Allegri AEM, Olivieri I, Bertelli E, Gallizia
A, et al. Diabetes insipidus–diagnosis and management. Hormone research
in paediatrics. 2012;77(2):69-84.
7. BRAVERMAN LE, MANCINI JP, MCGOLDRICK DM. Hereditary idiopathic
diabetes insipidus: a case report with autopsy findings. Annals of
Internal Medicine. 1965;63(3):503-8.
8. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, et
al. Central diabetes insipidus in children and young adults. New England
Journal of Medicine. 2000;343(14):998-1007.
9. Dhamija R, Babovic-Vuksanovic D. FGFR1-Related Hartsfield Syndrome.
In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, et
al., editors. GeneReviews(®). Seattle (WA): University of Washington,
Seattle
Copyright © 1993-2022, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All
rights reserved.; 1993.
10. Tasdemir S, Sahin I, Cayır A, Doneray H, Solomon BD, Muenke M, et
al. Holoprosencephaly: ZIC2 mutation in a case with panhypopituitarism.
Journal of Pediatric Endocrinology and Metabolism. 2014;27(7-8):777-81.
11. Olsen CL, Hughes JP, Youngblood LG, Sharpe‐Stimac M. Epidemiology of
holoprosencephaly and phenotypic characteristics of affected children:
New York State, 1984–1989. American journal of medical genetics.
1997;73(2):217-26.
12. Plawner L, Delgado M, Miller V, Levey E, Kinsman S, Barkovich A, et
al. Neuroanatomy of holoprosencephaly as predictor of function: beyond
the face predicting the brain. Neurology. 2002;59(7):1058-66.
13. Hahn JS, Hahn SM, Kammann Η, Barkovich AJ, Clegg NJ, Delgado MR, et
al. Endocrine disorders associated with holoprosencephaly. Journal of
Pediatric Endocrinology and Metabolism. 2005;18(10):935-42.
14. Javad H, Al-Yarubi S, Chacko AP, Sankhla D, Al-Futasi A,
Abdelmogheth AA, et al. Semilobar holoprosencephaly with neurogenic
hypernatraemia: two new cases. Sultan Qaboos University Medical Journal.
2013;13(3):E463.
15. Tekendo‐Ngongang C, Owosela B, Muenke M, Kruszka P, editors.
Comorbidity of congenital heart defects and holoprosencephaly is likely
genetically driven and gene‐specific. American Journal of Medical
Genetics Part C: Seminars in Medical Genetics; 2020: Wiley Online
Library.
16. Demir N, Doğan M, Peker E, Bulan K, Tuncer O. A very rare entity of
diabetes insipidus associated with Edwards syndrome. Genetics research.
2013;95(4):130-2.
17. Sng A, Loke K, Lim Y. A case of neonatal central diabetes insipidus
in a premature infant: challenges in diagnosis and management. Case Rep
J. 2018;2(2):010.
18. Fenske W, Allolio B. Current state and future perspectives in the
diagnosis of diabetes insipidus: a clinical review. The Journal of
Clinical Endocrinology & Metabolism. 2012;97(10):3426-37.
19. Sethi RV, Marino R, Niemierko A, Tarbell NJ, Yock TI, MacDonald SM.
Delayed diagnosis in children with intracranial germ cell tumors. The
Journal of pediatrics. 2013;163(5):1448-53.
20. Gregoire JR. Adjustment of the osmostat in primary aldosteronism.
Mayo Clinic proceedings. 1994;69(11):1108-10.
21. DeRubertis FR, Michelis MF, Davis BB. ”Essential” Hypernatremia:
Report of Three Cases and Review of the Literature. Archives of Internal
Medicine. 1974;134(5):889-95.
22. Godano E, Morana G, Di Iorgi N, Pistorio A, Allegri AEM, Napoli F,
et al. Role of MRI T2-DRIVE in the assessment of pituitary stalk
abnormalities without gadolinium in pituitary diseases. European journal
of endocrinology. 2018;178(6):613-22.
23. Dabrowski E, Kadakia R, Zimmerman D. Diabetes insipidus in infants
and children. Best Practice & Research Clinical Endocrinology &
Metabolism. 2016;30(2):317-28.
24. Garrahy A, Thompson CJ. Management of central diabetes insipidus.
Best Practice & Research Clinical Endocrinology & Metabolism.
2020;34(5):101385.
25. Raisingani M, Palliyil Gopi R, Shah B. Use of chlorothiazide in the
management of central diabetes insipidus in early infancy. Case reports
in pediatrics. 2017;2017.
26. Moritz ML, Ayus JC. Disorders of water metabolism in children.
Pediatrics in review. 2002;23(11):371.
27. Abraham MB, Rao S, Price G, Choong CS. Efficacy of
hydrochlorothiazide and low renal solute feed in neonatal central
diabetes insipidus with transition to oral desmopressin in early
infancy. International journal of pediatric endocrinology.
2014;2014(1):1-6.
28. Saifan C, Nasr R, Mehta S, Sharma Acharya P, Perrera I, Faddoul G,
et al. Diabetes insipidus: a challenging diagnosis with new drug
therapies. International Scholarly Research Notices. 2013;2013.
29. Van der Kaay DC, Van Heel WJ, Dudink J, van den Akker EL. Transient
diabetes insipidus in a preterm neonate and the challenge of
desmopressin dosing. Journal of Pediatric Endocrinology and Metabolism.
2014;27(7-8):769-71.